In order to obtain this action we must pay 24,61$ right now, In this post we are going to talk about the listed company Myriad Genetics Inc, its leaders are Jerry S. Lanchbury (Chief Scientific Officer), Kevin R. Haas (Chief Technology Officer), Paul J. Diaz (President, Chief Executive Officer & Director), R. Bryan Riggsbee (Chief Financial Officer, Treasurer & Executive VP), Thomas P. Slavin (Chief Medical Officer), they lead it to work in Biotechnology: In Vitro & In Vivo Diagnostic Substances especially in the North America region.
Yesterday this stock ended the day with a value of desconocido$.
The current range on the same day is from 23,77$ - 24,92$, with a percentage difference of 24,35$ quite wide that helps to be able to do day trading.
Their latest annual data shows an income of desconocido.
The opening price that appears as last recorded is desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].
Buscar
